Literature DB >> 10735597

Localization of nitric oxide synthase in human trophoblast cells: role of nitric oxide in trophoblast proliferation and differentiation.

M Sanyal1, T C Nag, C Das.   

Abstract

PROBLEM: There are conflicting reports about the isoform of nitric oxide synthase (NOS) present in trophoblast cells. In this study, we have examined the presence of different NOS isoforms in trophoblast cells. In addition, the role of nitric oxide (NO) in trophoblast function has also been studied by investigating the possible role of nitric oxide in trophoblast proliferation and differentiation. METHOD OF STUDY: NOS isoforms in primary-term trophoblast and JEG-3 cells were identified by immunocytochemistry. The intracellular localization of this enzyme was determined by confocal laser scanning microscopy. Trophoblast proliferation was studied by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasolium bromide (MTT) conversion assay and cellular differentiation was monitored by human chorionic gonodotropin (hCG) and progesterone secretion, measured by radioimmunoassay.
RESULTS: The immunoreactive NOS was present in human trophoblast cells of normal term placenta and JEG-3 cells (a choriocarcinoma cell line) maintained in culture. Nicotinamide adenine dinucleotide phosphate (NADPH)-dependent diaphorase activity overlapped with the immunostaining of NOS. Specific antibodies against the different isoforms of NOS detected the presence of neuronal-type NOS (nNOS) only. The other two isoforms, i.e., eNOS (endothelial) and iNOS (macrophage specific) were completely absent. The nNOS was localized in cell cytoplasm. In culture, JEG-3 cells normally undergo proliferation and cytotrophoblast cells in primary culture differentiate to form hormone-secreting syncytial cells. Sodium nitroprusside (SNP), a nitric oxide donor, when added to the culture, significantly increased proliferation of JEG-3 cells and inhibited the differentiation of cytotrophoblast cells. The arrest by SNP in the formation of syncytial cells was further evidenced by the low secretion profile of hCG and progesterone.
CONCLUSIONS: Our findings suggest for the first time the presence of nNOS in the human trophoblast cells and a previously unrecognized role of NO in trophoblast proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735597     DOI: 10.1111/j.8755-8920.2000.430202.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  6 in total

Review 1.  Does nitric oxide play a role in maternal tolerance towards the foetus?

Authors:  A González; A S López; E Alegre; J L Alcázar; N López-Moratalla
Journal:  J Physiol Biochem       Date:  2004-09       Impact factor: 4.158

2.  Analysis of nitroso-proteomes in normotensive and severe preeclamptic human placentas.

Authors:  Hong-hai Zhang; Yu-ping Wang; Dong-bao Chen
Journal:  Biol Reprod       Date:  2011-01-12       Impact factor: 4.285

3.  Immunobiology of trophoblast cells.

Authors:  C Das; V S Kumar; S Basak; S Gupta; S Kumar
Journal:  Indian J Clin Biochem       Date:  2000-08

4.  N,N-Dimethylacetamide Significantly Attenuates LPS- and TNFα-Induced Proinflammatory Responses Via Inhibition of the Nuclear Factor Kappa B Pathway.

Authors:  Ryan Pekson; Vladimir Poltoratsky; Samir Gorasiya; Sruthi Sundaram; Charles R Ashby; Ivana Vancurova; Sandra E Reznik
Journal:  Mol Med       Date:  2016-10-24       Impact factor: 6.354

5.  Nitric oxide levels and endothelial nitric oxide synthase gene polymorphisms in Turkish women with idiopathic recurrent miscarriage.

Authors:  Ebru Oztürk; Ozcan Balat; Sacide Pehlivan; Mete Gürol Uğur; Yelda Ozkan; Tuğçe Sever; Emine Namıduru; Seval Kul
Journal:  J Turk Ger Gynecol Assoc       Date:  2011-09-28

Review 6.  The Role of Oxidative Stress in Hypertensive Disorders of Pregnancy (Preeclampsia, Gestational Hypertension) and Metabolic Disorder of Pregnancy (Gestational Diabetes Mellitus).

Authors:  Wendy N Phoswa; Olive P Khaliq
Journal:  Oxid Med Cell Longev       Date:  2021-05-31       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.